Determining the Root Causes of Complications in Hemodialysis

Year : 2024 | Volume : | : | Page : –
By

Ibtisam Nazi Khan

Dr. Pankaj Kaul

  1. Assistant Professor Department of Allied & Health Sciences, Rayat Bahra University, Mohali, Punjab, India Punjab India
  2. Dean , Department of Allied & Health Sciences, Rayat Bahra University, Mohali, Punjab, India Punjab India

Abstract

As peritoneal dialysis and kidney transplantation, hemodialysis has been considered one of the most effective therapies for replacement of the kidney function. While this help to save the patients with the disease by decreasing morbidity /mortality/ rate, this medication has some side effects. These may manifest during the dialysis process alongside the ongoing treatment. Avoiding these barriers becomes crucial for improving the patients’ prognosis in this context, we are going to mention some short-term complication temporarily observable during sessions, such as muscle cramps or hypotension, or more related to the middle-long term, for instance, vascular access issues or electrolyte disorders. Hypotesnion, muscle cramps, hypoglycaemia, electrolyte disturbances, disequilibrium syndrome, hypocalcemia etc are common compications occur during Dialysis. In the extended course of dialysis treatment, patients often contend with complications such as bone disease, disruptions in endocrine function, infections, and cardiovascular issues. These challenges underscore the significance of ongoing vigilance and tailored care to manage the diverse health needs of individuals undergoing chronic hemodialysis. Hemodialysis is a crucial renal replacement therapy, alongside peritoneal dialysis and renal transplantation, utilized to manage end-stage renal disease (ESRD) by filtering waste products and excess fluids from the blood. Despite its efficacy in improving morbidity and mortality rates among renal patients, hemodialysis is associated with a variety of complications that can arise both during the dialysis sessions and with long-term use. Acute complications during dialysis sessions include hypotension, which is the most common, often resulting from rapid fluid removal. Muscle cramps can occur due to shifts in fluid and electrolyte balances. Hypoglycemia is another potential issue, particularly in diabetic patients, due to the glucose-free dialysate used during treatment. Electrolyte imbalances, such as hyperkalemia or hypokalemia, can also develop, requiring vigilant monitoring of serum levels to ensure proper management. Additionally, dialysis disequilibrium syndrome, characterized by neurological symptoms due to rapid changes in blood solute levels, and hypocalcemia, resulting from calcium removal during dialysis, are notable acute complications.
Long-term hemodialysis use can lead to more chronic complications, significantly impacting patient quality of life. Bone disease, or renal osteodystrophy, is prevalent due to disrupted calcium and phosphate metabolism. Endocrine disturbances, such as altered thyroid function and sexual dysfunction, are also common. Sepsis could arise from infection, especially at the site of the vascular access line they posed a great risk. In addition, longer dialysis patients are also predisposed to hypertension, left ventricular hypertrophy and other cardiovascular complications which are the leading causes of death for chronic dialysis patients. These complications make it evident that there exist significant gaps where integrated approaches need to be implemented to address all the risks that patient undergoing hemodialysis.

Keywords: Hemodialysis, hypotension, muscle cramps, infection, Hemodialysis complications.

How to cite this article: Ibtisam Nazi Khan, Dr. Pankaj Kaul. Determining the Root Causes of Complications in Hemodialysis. Emerging Trends in Metabolites. 2024; ():-.
How to cite this URL: Ibtisam Nazi Khan, Dr. Pankaj Kaul. Determining the Root Causes of Complications in Hemodialysis. Emerging Trends in Metabolites. 2024; ():-. Available from: https://journals.stmjournals.com/etm/article=2024/view=151259




References

  1. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC public health. 2008 Dec;8:1-3.
  2. Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison’s principles of internal medicine, 19e. New York, NY, USA:: Mcgraw-hill; 2015.
  1. Papadakis, Maxine A., Stephen J. McPhee, and M. CURRENT Rabow. Medical Diagnosis & Treatment. Mc Graw Hill: San Francisco, CA, USA, 2019.
  2. Carney EF. The impact of chronic kidney disease on global health. Nature Reviews Nephrology. 2020 May 1;16(5):251-2.
  3. Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, Adebayo OM, Afarideh M, Agarwal SK, Agudelo-Botero M, Ahmadian E. GBD Chronic Kidney Disease Collaboration: Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(709-733):32061315.
  4. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. The lancet. 2017 Mar 25;389(10075):1238-52.
  5. Pham PT, Pham PC, Wilkinson AH, Lew SQ. Renal abnormalities in sickle cell disease. Kidney international. 2000 Jan 1;57(1):1-8.
  6. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A. Worldwide access to treatment for end-stage kidney disease: a systematic review. The Lancet. 2015 May 16;385(9981):1975-82.
  7. Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, Morton RL, Oberbauer R, Postma MJ, Tonelli M, Biesen WV. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nature Reviews Nephrology. 2017 Jul;13(7):393-409.
  8. Mowatt G, Vale L, Perez J, Wyness L, Fraser C, MacLeod A, Daly C, Stearns SC. Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. NIHR Health Technology Assessment programme: Executive Summaries. 2003.
  9. Howell M, Walker RC, Howard K. Cost effectiveness of dialysis modalities: a systematic review of economic evaluations. Applied health economics and health policy. 2019 Jun 1;17:315-30.
  10. Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, Balkrishnan R, Bragg-Gresham J, Cao J, Chen JL, Cope E. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. American journal of kidney diseases. 2017 Mar 1;69(3):A7-8.
  11. Chaudhary K, Sangha H, Khanna R. Peritoneal dialysis first: rationale. Clinical Journal of the American Society of Nephrology. 2011 Feb 1;6(2):447-56.
  12. Li PK, Chow KM. Peritoneal dialysis–first policy made successful: perspectives and actions. American journal of kidney diseases. 2013 Nov 1;62(5):993-1005.
  13. Liu FX, Gao X, Inglese G, Chuengsaman P, Pecoits-Filho R, Yu A. A global overview of the impact of peritoneal dialysis first or favored policies: an opinion. Peritoneal Dialysis International. 2015 Jul;35(4):406-20.
  14. Yang CW, Harris DC, Luyckx VA, Nangaku M, Hou FF, Garcia GG, Abu-Aisha H, Niang A, Sola L, Bunnag S, Eiam-Ong S. Global case studies for chronic kidney disease/end-stage kidney disease care. Kidney international supplements. 2020 Mar 1;10(1):e24-48.
  15. Lee KY. A unified pathogenesis for kidney diseases, including genetic diseases and cancers, by the protein-homeostasis-system Kidney Res Clin Pract. 2017 Jun;36(2):132-144..
  16. Tattersall J, Dekker F, Heimbürger O, Jager KJ, Lameire N, Lindley E, Van Biesen W, Vanholder R, Zoccali C, ERBP Advisory Board. When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study. Nephrology dialysis transplantation. 2011 Jul 1;26(7):2082-6.
  17. Patel SS, Kimmel PL, Singh A. New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. InSeminars in nephrology 2002 Nov 1 (Vol. 22, No. 6, pp. 449-458). WB Saunders.
  18. Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Tamura MK, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American Journal of Kidney Diseases. 2014 May 1;63(5):713-35.
  19. Vadakedath S, Kandi V. Dialysis: a review of the mechanisms underlying complications in the management of chronic renal failure. Cureus. 2017 Aug 23;9(8).
  20. Mineshima M. The past, present and future of the dialyzer. InChronic Kidney Diseases-Recent Advances in Clinical and Basic Research 2015 (Vol. 185, pp. 8-14). Karger Publishers
  21. Canaud B, Chazot C, Koomans J, Collins A. Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities. J Bras Nefrol. 2019 Oct-Dec;41(4):550- .
  22. Salani M, Roy S, Fissell IV WH. Innovations in wearable and implantable artificial kidneys. American Journal of Kidney Diseases. 2018 Nov 1;72(5):745-51.
  23. Kallenbach JZ. Review of hemodialysis for nurses and dialysis personnel-e-book. St. Louis, MO: Elsevier Health Sciences. 2020.
  24. Frankel A. Temporary access and central venous catheters. European Journal of vascular and endovascular surgery. 2006 Apr 1;31(4):417-22.
  1. James Tattersall, Friedo Dekker, Olof Heimbürger, Kitty Jager, Norbert Lameire, Elizabeth Lindley, et,al.on behalf of the ERBP Advisory board, When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study, Nephrology Dialysis Transplantation, Volume 26, Issue 7, July 2011, Pages 2082–2086.
Ahead of Print Subscription Original Research
Volume
Received May 27, 2024
Accepted May 29, 2024
Published June 15, 2024
Views: 19